Protein Labeling Market Size, Share & Trends Analysis Report By Product (Reagents, Kits), By Application (Mass Spectrometry, Cell-based Assays), By Method, By Region, And Segment Forecasts, 2024 - 2030

Research Methodology

A three-pronged approach was followed for deducing the protein labeling market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for protein labeling market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of protein labeling market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Protein Labeling Market Categorization:

The protein labeling market was categorized into four segments, namely product (Reagents, Kits, Services), application (Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Protein Microarray, Mass Spectrometry), method (In-vitro Labeling Methods, In-vivo Labeling Methods), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The protein labeling market was segmented into product, application, method, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The protein labeling market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Protein labeling market companies & financials:

The protein labeling market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• Thermo Fisher Scientific, Inc. is a publicly held biotechnology company, established after a collaboration between Fisher Scientific and Thermo Electron. It offers products in life sciences, industrial & applied sciences, and clinical diagnostics. The company has operations in over 50 countries and offers products through the following brands: Thermo Scientific, Invitrogen, Unity Lab Services, Applied Biosystems, and Fisher Scientific. The Life Technologies Corporation has operated as a subsidiary of Thermo Fisher since April 2013. It acquired Affymetrix, Inc. in March 2016.

• Merck KGaA is a German multinational company that provides solutions and materials in healthcare. It operates through three sectors: healthcare, life science, and performance materials. It has operations in North America, Asia Pacific, Europe, Latin America, and Africa. Merck Group’s portfolio contains more than 300,000 products, including lab water systems, genome editing tools, antibodies & cell lines, and end-to-end bioprocessing systems.               

• PerkinElmer, Inc. delivers analytical instruments, diagnostic tools, software, genetic testing, and medical imaging components. Key business areas of the company include drug discovery, life sciences research, biotechnology, industrial applications, and environmental analysis. It is involved in various NGS sequencing applications for interactive sequencing and analysis services.

• Promega Corporation is a global biotechnology manufacturer providing solutions for cell analysis, energy metabolism, PCR, biologics, protein enzymes, genetics DNA markers, and analysis. Its portfolio consists of more than 4000 products, with technical and bioinformatics support. It operates in more than 16 countries and has distribution facilities in 100 countries. Promega holds several patents in drug discovery, cellular analysis, cell biology, and bioluminescence.       

• F. Hoffmann-La Roche Ltd. is involved in the development and manufacturing of diagnostic & pharmaceutical products. It operates through two segments: pharmaceuticals and diagnostics. The pharmaceuticals segment manufactures drugs for infectious, respiratory, cardiovascular, oncology, CNS, metabolic disorders, and autoimmune diseases. Roche Diagnostics is involved in market segments ranging from patient self-monitoring to clinical laboratory systems. Roche Professional Diagnostics is the company’s largest business segment and provides solutions, tests, and instrument systems to enable reliable & cost-effective delivery of results. Roche Tissue Diagnostics (Ventana Medical Systems), a member of the Roche group, is involved in the development of assays and kits for in-situ hybridization techniques. The company acquired GeneWEAVE Biosciences, which is involved in molecular diagnostics, along with Ariosa Diagnostics, Signature Diagnostics, CAPP Medical, and Kapa Biosystems in the sequencing business. It has operations in North & South America, Europe, Africa, Asia, and Oceania, and has around 26 manufacturing sites across the globe.       

• LGC Limited, formerly known as LGC Toddington Limited, is an international company that provides products & solutions in the life sciences sector, related to human healthcare, agri-food, and the environment. The company’s key products include reference materials, analytical testing products, genomic solutions, and related services. Through these products, the company serves customers in the pharmaceuticals, government, sports, and agriculture sectors, as well as several academic institutions & biotechnological entities. It has operations in more than 19 countries worldwide. LGC Standards is a division of the LGC Group. In November 2018, LGC acquired SeraCare Life Sciences, which strengthened its position in the clinical quality control industry.       

• New England Biolabs is a privately held U.S.-based company engaged in the discovery, production, and commercialization of enzymes for molecular biology applications. The company offers a variety of native and recombinant enzymes and research reagents for genomic research. Moreover, it focuses on alliances that enable the development of novel technologies to fulfill the demand for molecular diagnostics. The company is managed by a group of scientists and it is registered as a small business with the United States Small Business Administration.

• LI-COR, Inc. is a privately held company involved in the manufacturing & marketing of systems used in environmental & biological sciences, molecular biology, climatology, and translational research. Products such as analysis software, instruments, and reagents, provided by the company, are utilized across more than 100 countries in studies ranging from cancer research to climate change. The company has subsidiaries in Bad Homburg, Germany, and Cambridge, UK.

• General Electric (GE) Healthcare is a subsidiary of the General Electric Company. GE Healthcare operates as an industrial segment of General Electric Company. It is a global company that provides products and solutions for transformational medical devices and the pharmaceutical industry. The company offers various products and services related to medical diagnostics, biopharmaceutical manufacturing technologies, patient monitoring systems, performance solutions services, medical imaging & information technologies, and drug discovery.

• Jena Bioscience GmbH is a privately held biotechnology company developed by a team of scientists from the Max-Planck-Institute of Molecular Physiology based in Dortmund. The company manufactures a wide range of innovative reagents for customers operating in the research industry. The company manufactures its products in Germany as per global regulations of DIN EN ISO 9001 since 2008, and since 2015 as per DIN EN ISO 14001 standards, followed by EMAS EU verified environmental management guidelines since 2015.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Protein Labeling Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Protein Labeling Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.